WALTHAM, MA--(MARKET WIRE)--Jun 20, 2007 -- EyeGate Pharma, a privately held, specialty pharmaceutical company pioneering the use of iontophoresis technology to safely and non-invasively deliver therapeutics for ocular indications, today announced that Richard Guy, Ph.D., a leading expert on iontophoretic drug delivery and Professor at the University of Bath, UK, has been appointed to EyeGate’s Scientific Advisory Board.
